Are we undermining the value of palliative care through advanced cancer clinical trial consent language?

Puja J. Umaretiya; Jennifer P. Rubin; Jennifer M. Snaman; Christina Ullrich; Angela M. Feraco; Veronica Dussel; Joanne Wolfe; Elisha Waldman

doi:10.1002/cncr.33482

Are we undermining the value of palliative care through advanced cancer clinical trial consent language?

Puja J. Umaretiya^*, Jennifer P. Rubin, Jennifer M. Snaman, Christina Ullrich, Angela M. Feraco, Veronica Dussel, Joanne Wolfe, Elisha Waldman

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1954-1956
Number of pages	3
Journal	Cancer
Volume	127
Issue number	12
DOIs	https://doi.org/10.1002/cncr.33482
State	Published - Jun 15 2021

Keywords

advanced cancer
clinical trials
informed consent
palliative care
symptom management

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/cncr.33482

Cite this

@article{f4418474158e4ae4b19ca2fb227da9c4,

title = "Are we undermining the value of palliative care through advanced cancer clinical trial consent language?",

keywords = "advanced cancer, clinical trials, informed consent, palliative care, symptom management",

author = "Umaretiya, {Puja J.} and Rubin, {Jennifer P.} and Snaman, {Jennifer M.} and Christina Ullrich and Feraco, {Angela M.} and Veronica Dussel and Joanne Wolfe and Elisha Waldman",

year = "2021",

month = jun,

day = "15",

doi = "10.1002/cncr.33482",

language = "English (US)",

volume = "127",

pages = "1954--1956",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "12",

}